Per 1 ml dose of reconstituted vaccine:
Active substance:
Canine distemper virus not less than 104.0 TCID50*
Canine adenovirus 2 not less than 104.0 TCID50*
Canine parvovirus not less than 107.0 TCID50*
Canine parainfluenzavirus not less than 105.5 TCID50*

Target Species

Dogs

Indications for use, specifying the target species

For the active immunisation of dogs to reduce clinical signs of disease caused by canine distemper virus infection, to prevent clinical signs and reduce viral excretion caused by canine parvovirus infection, to reduce clinical signs and/or virus excretion caused by canine parainfluenza virus infection; to reduce clinical signs of canine contagious hepatitis and viral excretion due to canine adenovirus 1 infection and to reduce clinical signs of respiratory infection and viral excretion caused by adenovirus type 2 infection.

View Product Information